Q32 Bio Inc. (QTTB) Accumulated Expenses (2017 - 2026)

Q32 Bio has reported Accumulated Expenses for 10 years, with the latest figure at $3.8 million in Q2 2026.

• On a quarterly basis, Accumulated Expenses fell 12.74% year-over-year to $3.8 million in Q2 2026; TTM through Jun 2026 was $3.8 million, a 12.74% decrease from a year earlier, with the FY2025 full-year figure at $4.2 million, down 43.41% from the prior year.
• Accumulated Expenses was $3.8 million for Q2 2026 at Q32 Bio, up from $3.8 million in the prior quarter.
• The five-year high for Accumulated Expenses was $19.8 million in Q1 2024, with the low at $3.8 million in Q1 2026.
• Average Accumulated Expenses over 5 years is $10.2 million, with a median of $9.3 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Accumulated Expenses soared 104.41% in 2023, then sank 73.44% in 2025.
• Over 5 years, Accumulated Expenses stood at $18.7 million in 2022, then sank by 47.83% to $9.8 million in 2023, then declined by 23.39% to $7.5 million in 2024, then plunged by 43.41% to $4.2 million in 2025, then slipped by 9.36% to $3.8 million in 2026.
• The last three Accumulated Expenses figures came in at $3.8 million (Q2 2026), $3.8 million (Q1 2026), and $4.2 million (Q4 2025), per Business Quant data.